Home/Phlox Therapeutics/Margien Boels

MB

Margien Boels

Director of Operations

Phlox Therapeutics

Therapeutic Areas

Cardiovascular Genetic Diseases

Phlox Therapeutics Pipeline

Drug	Indication	Phase
RNA Therapy for Genetic Laminopathies	Cardiomyopathy due to LMNA mutations	Preclinical

Leadership Team at Phlox Therapeutics

Prof. dr. Eva Van Rooij

Founder and CSO

Prof. dr. Yigal Pinto

Founder and CMO

View full Phlox Therapeutics profile